Acquire and develop uranium properties in Niger, focusing on the Dasa deposit. Process electric arc furnace dust into zinc concentrates for sale to smelters. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
No real growth (3% a year). Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
This company is not turning a profit, so the market is pricing its sales instead: 134.1× for every dollar of annual revenue.
No analyst target is on record for this company.
An investor who bought at the very peak is down 91% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $787K a year. A small number, but proof the product has real buyers.
A loss of $16.4M against $787K in annual sales.
The stock sits at $0.36. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
Against everything we grade, GLATF lands somewhere in the middle. The grade moves as the numbers move.
The takeaway: GLATF is a high-risk stock — not yet profitable, and its future rides on its product catching on.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.